Delivery Order SPE2DB22D2206-SPE2DB24FJN02

Award Date 7/30/24
Potential Completion Date 8/20/24
Potential Value $25K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of PADCEV 30 MG VIALS, a medical product, with a ceiling value of $11,087.60 and a completion date of February 27, 2025. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of PADCEV 30 MG VIALS, with a ceiling value of $11,087.60 and a completion date of May 5, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $27,719.10, is for the provision of PADCEV 30 MG VIALS, a medical product. The contract has a period of performance that ends on February 11, 2025. The award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of PADCEV 30 MG vials. The contract has a ceiling value of $8,315.70 and a period of performance through July 25, 2025. This award is not set aside and represents an open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of PADCEV 30 MG VIALS, a pharmaceutical product. The contract has a ceiling value of $8,315.70 and is a firm fixed-price delivery order contract, with a period of performance ending on July 16, 2025. The contract is not set-aside and was awarded on June 24, 2025. AmerisourceBergen Drug Corp holds a significant...
This is a $19,994.04 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of PADCEV 30 MG vials. The contract has an ultimate completion date of October 2, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the delivery of a comprehensive...
This federal contract award, valued at $116,823.84, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of PADCEV 30 MG VIALS, and has an ultimate completion date of January 9, 2024. The contract is a firm fixed-price arrangement, and was not set aside for any specific business category. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of PADCEV 30 MG VIALS. The delivery order, valued at $27,719.00, is a firm fixed-price contract with a period of performance through May 9, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of PADCEV 30 MG VIALS. The contract has a ceiling value of $8,315.70 and a period of performance through January 30, 2025. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of PADCEV 30 MG vials, a specialty oncology medication, for a ceiling value of $29,999.16. The contract has an ultimate completion date of October 30, 2024 and was awarded on October 8, 2024. This order is not set aside for a specific business type. Amerisourcebergen holds a significant...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FJN02
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of PADCEV 30 MG VIALS. The contract is a firm fixed-price Indefinite Delivery Contract (IDC) with a maximum value of $24,999.30 and a period of performance through August 20, 2024. This award is part of a larger IDC with DLA Troop Support Medical that has a potential value of up to $999,999,999 and is used to provide a comprehensive range of medical commodities to military treatment programs and facilities worldwide. AmerisourceBergen has also been awarded an IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs. This contract does not have a set-aside designation.

Generated 10/29/24, 9:02 AM